NCT02817958View on ClinicalTrials.gov

Evaluation of Lymphadenectomy and Chemotherapy TIP on Inguinal Lymph Nodes in Squamous Cell Carcinoma of the Penis

PHASE2Active, not recruitingINTERVENTIONAL
Enrollment

37

Participants

Timeline

Start Date

October 17, 2016

Primary Completion Date

September 30, 2026

Study Completion Date

September 30, 2028

Conditions
Penile CancerSquamous Carcinoma
Interventions
DRUG

Chemotherapy TIP

Paclitaxel, ifosfamide, and cisplatin

Trial Locations (17)

13273

Institut Paoli-Calmettes, Marseille

14076

Centre FRANCOIS BACLESSE, Caen

25000

Chr Besancon, Besançon

31059

Institut Claudius Regaud, Toulouse

33075

Hôpital SAINT ANDRE, Bordeaux

44093

Clinique Urologique- Chu Hotel Dieu, Nantes

44805

ICO-René Gauducheau, Saint-Herblain

49055

ICO-Paul Papin, Angers

54519

Institut de Cancerologie de Lorraine, Nancy

63000

Chru Gabriel Montpied, Clermont-Ferrand

67091

Hopitaux Universitaires de Strasbourg, Strasbourg

69008

Centre Leon Berard, Lyon

69310

Chu Lyon Sud, Lyon

75010

Hopital Saint Louis, Paris

76031

Chu de Rouen, Rouen

87042

Ch de Limoges, Limoges

300029

Institut de Cancerologie Du Gard - Centre Oncogard, Nîmes

All Listed Sponsors
collaborator

National Cancer Institute, France

OTHER_GOV

lead

UNICANCER

OTHER

NCT02817958 - Evaluation of Lymphadenectomy and Chemotherapy TIP on Inguinal Lymph Nodes in Squamous Cell Carcinoma of the Penis | Biotech Hunter | Biotech Hunter